|
|
||||||||
Ann Thorac Surg 2003;75:1362-1363
© 2003 The Society of Thoracic Surgeons
Department of Cardiac Surgery, Bristol Heart Institute, Bristol Royal Infirmary, Upper Maudlin Street, Bristol BS2 8HW, United Kingdom
To the Editor:
We thank Dr Millner for his comments. The main aim of our observational study [1] was to assess the overall effectiveness of off- and on-pump coronary surgery in high-risk patients. We did not focus on blood-saving techniques because in this group of patients many confounding variables may affect blood loss and transfusion requirement. Such end points are best investigated with controlled trials like the BHACAS 1 and 2 [2], recently conducted at our institute, which showed that blood loss and transfusion requirement were significantly higher in the on-pump compared with the off-pump group. In the off-pump group, less than 5% of patients required fresh-frozen plasma (FFP) and platelet (PLT) units, while in the on-pump group, it was 30% and 25%, respectively. These findings were supported by the significantly higher derangement of hematological and coagulation indices observed in the on-pump group [3].
After these results, since the beginning of 1999, we have used tranexamic acid (TA) in patients undergoing on-pump coronary surgery. Simultaneously, we started to use, selectively, the cell saver (CS) during off-pump coronary surgery, when the procedure is performed by a supervised trainee, and when temporary proximal coronary snaring is not used before the insertion of the intracoronary shunt either because of contraindication or surgeon preference. Due to this selective practice, the use of CS in the off-pump group of our high-risk series [1] was 39% (19% over the same period in the whole off-pump population).
Following Dr Millners comments, we have performed a new adjusted logistic regression analysis for blood loss and transfusion requirement, including in the statistical model the use of TA and CS as well as all other previous variables (Table 1). This analysis confirmed that the effect of off-pump surgery on blood loss >1,000 mL was not significant. However, the use of off-pump surgery still had a significant effect on any red blood cell (RBC) and PLT transfusions. Interestingly, despite the higher requirement of RBC transfusion in the on-pump group, on discharge, a hemoglobin level < 10 g/dL was recorded in 47% of patients in this group as compared with 29% in the off-pump group. The effect of off-pump surgery on the use of any FFP transfusion was moderately significant in the original adjusted analysis, but only reached a borderline significance in the new model.
|
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |